10x Genomics acquires Spatial Transcriptomics Holdings AB
The deal at a glance
10x Genomics acquired Spatial Transcriptomics Holdings AB, a transaction completed in December 2018, structured as Stock acquisition with ongoing contingent/royalty payments tied to Spatial Transcriptomics and Visium product revenue (headline value not disclosed).
Spatial Transcriptomics Holdings AB operates in Spatial Genomics / Visium, is based in Stockholm, Sweden. Acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in spatial genomics whose technology bridges microscopy and RNA sequencing to capture the whole transcriptome from an intact tissue section. The technology formed the foundation of 10x's Visium platform.
Add spatial context to single-cell analysis, enabling researchers to understand not only what is in a cell but how cells are organized relative to one another across oncology, neurology and immunology.
Foundational technology for the Visium Spatial Gene Expression platform; ongoing contingent and royalty payments tied to Visium revenue. Visium Spatial platform
No advisory firms have been disclosed for this transaction.